Helicobacter pylori gastritis
Conditions
Interventions
As eradication of H.pylori vonoprazan20mg,amoxicillin750mg and clarithromycin200mg of three drugs at tha same time twice a day for 7days to oral administration
Sponsors
National Center for Global Health and Medicine.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1)Subject consent was obtained by sentence 2)20 years old or more of the subject 3)Subject to the upper gastrointestinal tract diseases such as gastritis and peptic ulcer is suspected
Exclusion criteria
Exclusion criteria: 1)not subject to upper endoscopy 2)eradication of H.pylori in the past 3)Subjects that have been administered antibiotics to be used as a systemic administration such as orally or by injection within 28 days 4)Subjects who are taking anticoagulants 5)Subjects that are oral anti-platelet agent 2 agent or more 6)Subjects having an upper gastrointestinal tract disease requiring treatment with proton pump inhibitors 7)Subjects with a merger or history of gastric acid hypersecretory disease (Zollinger-Ellison syndrome, etc.) 8) with a history of hypersensitivity to components of the drug to be used in the present study subjects 9) subject suspected of esophageal cancer or stomach cancer 10) subjects with a history of gastrectomy or vagotomy 11)pregnant or lactating subject
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| triple therapy of eradication rate point we want to calculate the estimated value and the 95% confidence interval. | — |
Countries
Japan
Contacts
Public ContactOkubo hidetaka
National Center for Global Health and Medicine. Gastroenterological medicine
Outcome results
None listed